Crescita Therapeutics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 60.00% vs -30.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -33.33% vs -50.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.60",
          "val2": "3.50",
          "chgp": "60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.80",
          "val2": "-0.70",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.20",
          "val2": "-0.90",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-213.80%",
          "val2": "-300.30%",
          "chgp": "8.65%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.65% vs 12.00% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 96.43% vs -40.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.10",
          "val2": "19.60",
          "chgp": "7.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.50",
          "val2": "-1.80",
          "chgp": "127.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.90",
          "val2": "0.10",
          "chgp": "-1,000.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "-2.80",
          "chgp": "96.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-48.40%",
          "val2": "-164.20%",
          "chgp": "11.58%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

5.60

3.50

60.00%

Operating Profit (PBDIT) excl Other Income

-0.80

-0.70

-14.29%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

-1.20

-0.90

-33.33%

Operating Profit Margin (Excl OI)

-213.80%

-300.30%

8.65%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 60.00% vs -30.00% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -33.33% vs -50.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

21.10

19.60

7.65%

Operating Profit (PBDIT) excl Other Income

0.50

-1.80

127.78%

Interest

0.00

0.10

-100.00%

Exceptional Items

-0.90

0.10

-1,000.00%

Consolidate Net Profit

-0.10

-2.80

96.43%

Operating Profit Margin (Excl OI)

-48.40%

-164.20%

11.58%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 7.65% vs 12.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 96.43% vs -40.00% in Dec 2024

All Annual Results